Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF). | Cell Calcium | 2024 | 38823350 | PubTator, text mining | PubMed |
| Myocardial SERCA2 Protects Against Cardiac Damage and Dysfunction Caused by Inhaled Bromine. | J Pharmacol Exp Ther | 2024 | 38772719 | PubTator, text mining | PubMed |
| Large Roles of Small Proteins. | Annu Rev Microbiol | 2024 | 38772630 | PubTator, text mining | PubMed |
| Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice. | Mol Cell Biol | 2024 | 38725392 | PubTator, text mining | PubMed |
| Serca Uncoupling May Facilitate Cold Acclimation in Dark-Eyed Juncos (Junco hyemalis) without Regulation by Sarcolipin or Phospholamban. | Integr Comp Biol | 2024 | 38650061 | PubTator, text mining | PubMed |
| A Heterozygous Phospholamban Variant (p.R14del) Leads to Left Ventricular Involvement and Heart Failure Phenotypes in Arrhythmogenic Right Ventricular Cardiomyopathy. | Phenomics | 2024 | 38605909 | PubTator, text mining | PubMed |
| Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes. | Heliyon | 2024 | 38596141 | PubTator, text mining | PubMed |
| Phospholamban inhibits the cardiac calcium pump by interrupting an allosteric activation pathway. | J Biol Chem | 2024 | 38583863 | PubTator, text mining | PubMed |
| Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study. | Europace | 2024 | 38558121 | PubTator, text mining | PubMed |
| Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma. | World J Clin Oncol | 2024 | 38455128 | PubTator, text mining | PubMed |
| Mechanotransduction-induced interplay between phospholamban and yes-activated protein induces smooth muscle cell hypertrophy. | Mucosal Immunol | 2024 | 38423390 | PubTator, text mining | PubMed |
| ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy. | Heart Rhythm | 2024 | 38403235 | PubTator, text mining | PubMed |
| Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review. | J Cardiovasc Dev Dis | 2024 | 38392255 | PubTator, text mining | PubMed |
| Missense variants in phospholamban and cardiac myosin binding protein identified in patients with a family history and clinical diagnosis of dilated cardiomyopathy. | Biochim Biophys Acta Mol Cell Res | 2024 | 38387507 | PubTator, text mining | PubMed |
| Structural Dynamics of Protein Interactions Using Site-Directed Spin Labeling of Cysteines to Measure Distances and Rotational Dynamics with EPR Spectroscopy. | Appl Magn Reson | 2024 | 38371230 | PubTator, text mining | PubMed |
| FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a. | Redox Biol | 2024 | 38359748 | PubTator, text mining | PubMed |
| Exploring Health Care Disparities in Genetic Testing and Research for Hereditary Cardiomyopathy: Current State and Future Perspectives. | Glob Med Genet | 2024 | 38304308 | PubTator, text mining | PubMed |
| Seeking for Regulatory Mechanisms of Phospholamban Expression. | Circ Res | 2024 | 38300986 | PubTator, text mining | PubMed |
| Physiological and molecular predictors of cycling sprint performance. | Scand J Med Sci Sports | 2024 | 38268080 | PubTator, text mining | PubMed |
| Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium. | Sci Adv | 2024 | 38266090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=10